A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells

Journal of Experimental Medicine

Volumn 190, Issue 3, 1999, Pages 311-322

  Wesley, Umadevi V ^a   Albino, Anthony P ^a,c   Tiwari, Shakuntala ^a   Houghton, Alan N ^a,b  

^a Department of Obstetrics Gynecology   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

Differentiation; Fibroblast activating protein ; Melanoma; Serine protease; Tumorigenicity

Indexed keywords

ALANINE; DIPEPTIDYL PEPTIDASE IV; SERINE; SERINE PROTEINASE;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CARCINOGENICITY; CELL DIFFERENTIATION; CELL SURVIVAL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MELANOCYTE; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD26; APOPTOSIS; CELL CYCLE; CELL DIVISION; CULTURE MEDIA, CONDITIONED; GELATINASES; GROWTH INHIBITORS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MELANOCYTES; MELANOMA; MEMBRANE PROTEINS; PHENOTYPE; SERINE ENDOPEPTIDASES; TUMOR CELLS, CULTURED;

EID: 0033517124     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.3.311     Document Type: Article

References (38)

1. Schrader, W.P., and A.R. Stacy. 1977. Purification and subunit structure of adenosine deaminase from human kidney. J. Biol. Chem. 252:6409-6415.
2. Houghton, A.N., A. Albino, C. Cordon-Cardo, L.J. Davis, and M. Eisinger. 1988. Cell surface antigens of human melanocytes and melanoma. Expression of adenosine deaminase binding protein is extinguished with melanocyte transformation. J. Exp. Med. 167:197-212.
3. Morimoto, C., and S. Schlossman. 1998. The structure and function of CD26 in the T-cell immune response. Immunol. Rev. 61:55-70.
4. Schrader, W.P., C.A. West, A.D. Miczek, and E.K. Norton. 1990. Characterization of the adenosine deaminase-adenosine deaminase complexing protein binding reaction. J. Biol. Chem. 265:19312-19318.
5. Schrader, W.P., and B. Pollara. 1978. Localization of an adenosine deaminase-binding protein in human kidney. J. Lab. Clin. Med. 92:656-662.
6. Fogh, J. 1975. Human Tumor Cells In Vitro. Plenum Press, New York. 183 pp.
7. Herbschleb-Voogt, E., J. Ten Kate, and P. Meera Khan. 1983. Adenosine deaminase complexing protein: a transformation sensitive protein with potentials of a cancer marker. Anticancer Res. 3:95-100.
8. Ten Kate, J., N.M.W. Dinjens, P. Meera Khan, and F.D. Bosman. 1986. Adenosine deaminase complexing protein in cancer studies. Anticancer Res. 6:983-988.
9. Bogenrieder, T., C.L. Finstad, R.H. Freeman, C.N. Papandreou, H.I. Scher, A.P. Albino, V.E. Reuter, and D.M. Nanus. 1997. Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue. Prostate. 33:225-232.
10. Dinjens, W.N., J. Ten Kate, J.A. Kirch, H.J. Tanke, E.P. Van der Linden, H.F. Van den Ingh, G.J. Van Steenbrugge, P. Meera Khan, and F.T. Bosman. 1990. Adenosine deaminase complexing protein (ADCP) expression and metastatic potential in prostatic adenocarcinomas. J. Pathol. 160:195-201.
11. Ten Kate, J., H.F. van den Ingh, P.M. Khan, and F.T. Bosman. 1986. Adenosine deaminase complexing protein (ADCP) immunoreactivity in colorectal adenocarcinoma. Int. J. Cancer. 37:479-485.
12. Sakamoto, J., T. Watanabe, S. Teramukai, S. Akiyama, T. Morimoto, H. Takagi, H. Nakazato, R. Ueda, and T. Takahashi. 1993. Distribution of adenosine deaminase binding protein in normal and malignant tissues of the gastrointestinal tract studied by monoclonal antibodies. J. Surg. Oncol. 52: 124-143.
13. Morrison, M.E., S. Vijayasaradhi, D. Engelstein, A.P. Albino, and A.N. Houghton. 1993. A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase. J. Exp. Med. 177:1135-1143.
14. Albino, A.P., Z. Sozi, D.M. Nanus, C.S. Jhanwar, and A.N. Houghton. 1992. Malignant transformation of human melanocytes: induction of a complete melanoma phenotype and genotype. Oncogene. 7:2315-2321.
15. Rettig, W.J., P. Garin-Chesa, J.H. Healey, S.L Su, H.L. Ozer, M. Schwab, A.P. Albino, and L.J. Old. 1993. Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin. Cancer Res. 53:3327-3335.
16. Gosse, M., S. Freundlieb, G. Bender, G. Muller, W. Hillen, and H. Bujard. 1995. Transcriptional activation by tetracyclines in mammalian cells. Science. 268:1766-1769.
17. Houghton, A.N., M. Eisinger, A.P. Albino, J.G. Cairncross, and L.J. Old. 1982. Surface antigens of melanocytes and melanomas: markers of melanocyte differentiation and melanoma subsets. J. Exp. Med. 156:1755-1766.
18. Houghton, A.N., F.X. Real, L.J. Davis, C. Cordon-Cardo, and L.J. Old. 1987. Phenotypic heterogeneity of melanoma. Relation to the differentiation program of melanoma cells. J. Exp. Med. 164:812-829.
19. Eisinger, M., and O. Marko. 1982. Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. Proc. Natl. Acad. Sci. USA. 79: 2018-2022.
20. Garin-Chesa, P., L.J. Old, and W.J. Rettig. 1990. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc. Natl. Acad. Sci. USA. 87:7235-7239.
21. Xu, Y., S. Vijayasaradhi, and A.N. Houghton. 1998. The cytoplasmic tail of the mouse brown locus product determines intracellular stability and export from the endoplasmic reticulum. J. Invest. Dermatol. 110:324-331.
22. Kojima, K., T. Hama, T. Kato, and T. Nagatsu. 1980. Rapid chromatographic purification of dipeptidyl peptidase IV in human submaxillary gland. J. Chromatogr. 189:233-240.
23. Thomson, T.M., F.X. Real, S. Murakami, C. Cordon-Cardo, L.J. Old, and A.N. Houghton. 1988. Differentiation antigens of melanocytes and melanoma: analysis of melanosome and cell surface markers of human pigmented cells with monoclonal antibodies. J. Invest. Dermatol. 4:459-466.
24. Sporn, M.B., and G.J. Todaro. 1980. Autocrine secretion and malignant transformation of cells. N. Engl. J. Med. 303: 878-880.
25. Rodeck, U., M. Herlyn, H.D. Menssen, R.W. Furlanetto, and H. Koprowski. 1987. Metastatic but not primary melanoma cell lines grow in vitro independently of exogenous growth factors. Int. J. Cancer. 40:687-690.
26. Real, F.X., B. Fliegel, and A.N. Houghton. 1988. Surface antigens of human melanoma cells cultured in serum free medium: induction of expression of major histocompatibility complex class II antigen. Cancer Res. 48:686-693.
27. Werb, Z. 1997. ECM and cell surface proteolysis: regulating cellular ecology. Cell. 191:439-442.
28. Brown, D.D., Z. Wang, J.D. Furlow, A. Kanamori, R.A. Schwartzman, B.F. Remo, and A. Pinder. 1996. The thyroid hormone-induced tail resorption program during Xenopus laevis metamorphosis. Prof. Natl. Acad. Sci. USA. 93:1924-1929.
29. Yamamura, K., S.I. Kamada, K. Nakagawa, M. Ichihashi, and Y. Tsujimoto. 1996. Accelerated disappearance of melanocytes in bcl-2-deficient mice. Cancer Res. 56:3546-3550.
30. Ramsay, J.A., L. From, and H.J. Kahn. 1995. bcl-2 protein expression in melanocytic neoplasms of the skin. Mod. Pathol. 8:150-154.
31. Papandreou, C.N., B. Usmani, Y. Geng, T. Bogenrieder, R. Freeman, S. Wilk, C.L. Finstad, V.E. Reuter, C.T. Powell, D. Scheinberg, et al. 1998. Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgenindependent progression. Nat. Med. 4:50-57.
32. Oravecz, T., M. Pall, G. Roderiquez, M.D. Gorrell, M. Ditto, N.Y. Nguyen, R. Boykins, E. Unsworth, and M.A. Norcross. 1997. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage J. Exp. Med. 186:1865-1872.
33. Van Coillie, E., P. Proost, I. Van Aelst, S. Struyf, M. Polfliet, I. De Meester, D.J. Harvey, J. Van Damme, and G. Opdenakker. 1998. Functional comparison of two human monocyte chemotactic protein-2 isoforms. Role of the aminoterminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV. Biochemistry. 37:12672-12680.
34. Proost, P., I. De Meester, D. Schols, S. Struyf, A.M. Lambeir, A. Wuyts, G. Opdenakker, E. De Clercq, S. Scharpe, and J. Van Damme. 1998. Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J. Biol. Chem. 273:7222-7227.
35. Proost, P., S. Struyf, D. Schols, C. Durinx, A. Wuyts, J.P. Lenaerts, E. De Clercq, I. De Meester, and J. Van Damme. 1998. Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1α. FEBS Lett. 432:73-76.
36. Shioda, T., H. Kato, Y. Ohnishi, K. Tashiro, M. Ikegawa, E.E. Nakayama, H. Hu, A. Kato, Y. Sakai, H. Liu, et al. 1998. Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1α (SDF-1α) and SDF-1β are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage. Proc. Natl. Acad. Sci. USA. 95:6331-6336.
37. Drucker, D.J., Q. Shi, A. Crivici, M. Sumner-Smith, W. Tavares, M. Hill, L. DeForest, S. Cooper, and P.L. Brubaker. 1997. Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV. Nat. Biotechnol. 15:673-677.
38. Medeiros, M.S., and A.J. Turner. 1994. Post-secretory processing of regulatory peptides: the pancreatic polypeptide family as a model example. Biochimie. 76:283-287.